Bjørn Tore Gjertsen

The paper uses mass cytometry to analyze immune and signaling profiles in CML patients within hours of TKI treatment to predict 12-month treatment response.

This study shows that mutant NPM1 forms nuclear condensates called C-bodies, which are essential for leukemic gene expression and cell survival, and identifies them as potential therapeutic targets.

This study examines immune remodeling after aHSCT in RRMS patients, finding lineage-specific changes in T and B cells rather than full immune restoration.

This paper introduces a bioinformatics framework for automated cell type annotation and patient stratification using CyTOF data, showing improved sensitivity and specificity and predictive survival analysis in leukemia.

This study shows that nilotinib and interferon-alpha increase tunneling nanotube formation in CML cells by enhancing β1-integrin-mediated adhesion.